Ki-67 is expressed as a percentage and, while high proliferation rates have been suggested to correlate with malignancy, low (1–2%) and moderate (3–4%) values can be used to guide the choice of management method for the tumor residue. The gene discussed is MKI67; the disease is neoplasm.